Ionis Pharmaceuticals, Inc.
Compounds and methods for modulating C90RF72
Last updated:
Abstract:
Disclosed herein are compounds and methods for modulating C9orf72 transcript. Such compounds and methods are useful to treat, prevent, or ameliorate neurodegenerative diseases in an individual in need thereof.
Status:
Grant
Type:
Utility
Filling date:
2 Nov 2016
Issue date:
1 Mar 2022